|
Market Closed -
Warsaw S.E.
11:20:00 2026-10-16 am EDT
|
5-day change | 1st Jan Change | ||
| 134.00 PLN | +0.90% |
|
+3.55% | -1.62% |
| Sep. 30 | Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| May. 27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 109M | - | - | |||
| 68.98B | |||||
| 53.15B | |||||
| 50.83B | |||||
| 44.61B | |||||
| 40.57B | - | - | - | - | - |
- Stock Market
- Stocks
- SCP Stock
- Charts Scope Fluidics S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
